perfluorobutane has been researched along with Coronary Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aristizabal, D; Cheirif, J; Collins, TJ; Meza, MF; Mobarek, S; Murgo, JP; Ramee, SR; Shuler, S; Sonnemaker, R; White, CJ | 1 |
| Cotter, B; DeMaria, AN; Ohmori, K | 1 |
| Aas, M; Molstad, P; Myreng, Y; Nossen, JO; Oftedal, B; Stoksflod, L; Ytre-Arne, K | 1 |
| Christensen, G; DeMaria, AN; Leistad, E; Ohmori, K; Peterson, TA | 1 |
| Beppu, S; Hirayama, H; Ishikura, F; Kashiwagi, Y; Kayano, H; Kobayashi, H; Yagura, S | 1 |
| Cwajg, J; Dittrich, H; Kricsfeld, D; O'Leary, E; Porter, TR; Xie, F | 1 |
| Baisch, C; Kuersten, B; Li, P; Liu, Z; Locricchio, E; Murthy, TH; Rafter, P; Vannan, M | 1 |
1 review(s) available for perfluorobutane and Coronary Disease
| Article | Year |
|---|---|
NC 100100. DD 723, NUS, Sonazoid.
Topics: Animals; Clinical Trials as Topic; Coronary Disease; Drug Industry; Ferric Compounds; Humans; Iron; Oxides | 2002 |
1 trial(s) available for perfluorobutane and Coronary Disease
| Article | Year |
|---|---|
Safety of the transpulmonary ultrasound contrast agent NC100100: a clinical and haemodynamic evaluation in patients with suspected or proved coronary artery disease.
Topics: Adult; Aged; Contrast Media; Coronary Disease; Dose-Response Relationship, Drug; Female; Ferric Compounds; Hemodynamics; Humans; Iron; Male; Middle Aged; Oxides; Pulmonary Circulation; Ultrasonography | 1999 |
6 other study(ies) available for perfluorobutane and Coronary Disease
| Article | Year |
|---|---|
Myocardial contrast echocardiography in human beings: correlation of resting perfusion defects to sestamibi single photon emission computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary Vessels; Diastole; Echocardiography; Female; Ferric Compounds; Humans; Image Processing, Computer-Assisted; Iron; Linear Models; Male; Meglumine; Middle Aged; Myocardial Infarction; Observer Variation; Oxides; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Myocardial contrast echocardiography: too much, too soon?
Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Echocardiography; Ferric Compounds; Humans; Infusions, Intravenous; Iron; Myocardial Contraction; Oxides; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1998 |
Quantitative assessment of myocardial perfusion during graded coronary artery stenoses by intravenous myocardial contrast echocardiography.
Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dogs; Echocardiography; Ferric Compounds; Iron; Myocardial Infarction; Oxides; Regional Blood Flow; Sensitivity and Specificity | 2001 |
[Usefulness of intravenous myocardial contrast echocardiography in rats].
Topics: Animals; Contrast Media; Coronary Disease; Echocardiography; Ferric Compounds; Injections, Intravenous; Iron; Male; Oxides; Rats; Rats, Wistar; Transducers | 2001 |
Detection of angiographically significant coronary artery disease with accelerated intermittent imaging after intravenous administration of ultrasound contrast material.
Topics: Adult; Aged; Albumins; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Disease; Dobutamine; Echocardiography; Exercise Test; Female; Fluorocarbons; Humans; Image Enhancement; Male; Middle Aged; Myocardial Contraction; Observer Variation; Predictive Value of Tests | 2000 |
Ultraharmonic myocardial contrast imaging: in vivo experimental and clinical data from a novel technique.
Topics: Adult; Animals; Contrast Media; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; Echocardiography; Female; Fluorocarbons; Humans; Image Enhancement; Male; Microspheres; Phosphodiesterase Inhibitors; Ultrasonics | 2001 |